Hospitals held the dominant position in the concussion market in 2025, accounting for a 41.45% share. Their dominance is sustained by their role as the primary point of care for patients presenting with head injuries, especially in urgent and acute settings where rapid neurological evaluation is required. Hospitals also concentrate the clinical infrastructure, specialist access, and imaging capabilities needed to assess concussion cases efficiently, which keeps patient volume and diagnostic activity anchored within this end-use segment of the concussion market.

Research Centers are emerging as the fastest-growing end-use segment in the concussion market as attention shifts toward improving diagnostic precision, recovery tracking, and evidence-based care pathways. Their growth is being aided by rising clinical and scientific interest in concussion biomarkers, neurocognitive assessment tools, and long-term outcome studies, areas where research-focused institutions are better positioned than routine care settings. Relative to other end users, Research Centers are gaining momentum because they sit closest to innovation and validation efforts that are shaping future concussion assessment and management practices.

Assessment and Treatment Segment Analysis: Diagnosis (Largest Segment) vs Treatment (Fastest-Growing Segment)

Within the concussion market, Diagnosis led the assessment and treatment segment in 2025 with a 69.31% share. This leadership reflects the practical reality that nearly every suspected concussion case must first pass through clinical evaluation, symptom assessment, and confirmatory testing before any treatment pathway is defined. The high volume of first-line screening and diagnostic work across emergency, hospital, and specialty settings keeps Diagnosis at the center of utilization in the concussion market, reinforcing its larger share relative to downstream interventions.

Treatment is the fastest-growing segment in the concussion market because care models are moving beyond initial identification toward more structured symptom management and recovery support. Growth is being driven by the increasing need to address persistent post-concussion symptoms, monitor rehabilitation progress, and tailor interventions to individual patient recovery patterns. Compared with diagnosis, which is already widely established, Treatment has more room to expand as providers and care systems place greater emphasis on active management rather than one-time assessment alone.